Healthcare
Curaleaf Hldgs Inc.(CURLF)
Live Price
Offline$10.07
+5.09% today
1Y Change
+293.65%
Window
Jun 25, 2025 โ Jun 12, 2026
- Market Cap
- $2.72B
- Revenue Growth
- +0.9%
- EPS Growth
- -6.9%
- Dividend Yield
- 0.0%
Coverage: 243 bars ยท Jun 25, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Curaleaf Hldgs Inc. (CURLF) is a Healthcare stock with a market cap of $2.72B and listed on OTC. The stock last traded around $10.07 and up 293.7% across the available one-year price window (Jun 25, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +0.9%, EPS growth of -6.9%, a dividend yield of 0.0%. What stands out right now is revenue +0.9%, EPS -6.9%, free cash flow +14.7% with operating margin 1.4% and ROIC 0.7%. Valuation is more restrained than many high-expectation growth names at price/sales 2.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CURLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+0.9% vs +7.6% peer median
Operating Margin
Below sector median
+1.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +0.9% and EPS is at -6.9%, with operating margin around 1.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.2% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +9.4% | +10.9% | -2.0% |
2026 Feb 26, 2026 | +37.5% | -4.2% | -9.0% | -11.6% |
2025 Nov 5, 2025 | +14.3% | -14.7% | -2.5% | -6.7% |
Benchmark Edge
CURLF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CURLF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CURLF Max Drawdown
-59.79%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CURLF and SPY.
Company Overview
Curaleaf Hldgs Inc.
OTC
Curaleaf Holdings, Inc. is a leading international cannabis company focused on producing and distributing medical and adult-use cannabis products. It operates a vertically integrated model, encompassing cultivation, processing, branding, and retail through its network of dispensaries across multiple states in the United States and select international markets. The company offers a diverse portfolio of branded products, including flower, vapes, edibles, and concentrates under well-known labels such as Select, Grassroots, and Elevated, catering to both recreational and medicinal consumers. Curaleaf Holdings, Inc. emphasizes wellness, education, and responsible consumption through initiatives like Curaleaf Rewards and resources on cannabis vocabulary and safe use. With a significant presence in the rapidly evolving cannabis industry, it plays a pivotal role in advancing product innovation, market expansion, and compliance amid varying regulatory landscapes, serving physicians, caregivers, and individual users while maintaining a commitment to quality and community impact.
- Leadership
- Mr. Boris Alexis Jordan
- Employees
- 5.6k
- Street Address
- 290 Harbor Drive, Suite 2035
- Mailing
- Stamford, CT, 06902
- Region
- Stamford, CT, United States
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 17.0
- Price/Sales
- 2.1
- Price/Book
- 3.6
Growth
- Revenue
- +0.9%
- EPS
- -6.9%
- Free Cash Flow
- +14.7%
Profitability
- Gross Margin
- 40.9%
- Operating Margin
- 1.4%
- Net Margin
- -18.1%
- ROE
- -28.6%
- ROIC
- 0.7%
Balance Sheet
- Debt/Equity
- 1.37
- Current Ratio
- 1.52
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.